221 related articles for article (PubMed ID: 31542087)
1. Comparison between vacuum aspiration and forceps plus blunt curettage for the evacuation of complete hydatidiform moles.
Sato A; Usui H; Shozu M
Taiwan J Obstet Gynecol; 2019 Sep; 58(5):650-655. PubMed ID: 31542087
[TBL] [Abstract][Full Text] [Related]
2. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a routine second curettage for hydatidiform mole: a cohort study.
Yamamoto E; Nishino K; Niimi K; Watanabe E; Oda Y; Ino K; Kikkawa F
Int J Clin Oncol; 2020 Jun; 25(6):1178-1186. PubMed ID: 32144509
[TBL] [Abstract][Full Text] [Related]
4. Gestational Trophoblastic Neoplasia From Genetically Confirmed Hydatidiform Moles: Prospective Observational Cohort Study.
Usui H; Qu J; Sato A; Pan Z; Mitsuhashi A; Matsui H; Shozu M
Int J Gynecol Cancer; 2018 Nov; 28(9):1772-1780. PubMed ID: 30358702
[TBL] [Abstract][Full Text] [Related]
5. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
Sato A; Usui H; Shozu M
Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
[TBL] [Abstract][Full Text] [Related]
6. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
[TBL] [Abstract][Full Text] [Related]
7. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
8. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
Stone M; Bagshawe KD
Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
[TBL] [Abstract][Full Text] [Related]
10. Manual Compared With Electric Vacuum Aspiration for Treatment of Molar Pregnancy.
Padrón L; Rezende Filho J; Amim Junior J; Sun SY; Charry RC; Maestá I; Elias KM; Horowitz N; Braga A; Berkowitz RS
Obstet Gynecol; 2018 Apr; 131(4):652-659. PubMed ID: 29528932
[TBL] [Abstract][Full Text] [Related]
11. Gestational Trophoblastic Neoplasia and Pregnancy Outcome After Routine Second Curettage for Hydatidiform Mole A Retrospective Observational Study.
Kan M; Yamamoto E; Niimi K; Tamakoshi K; Sekiya Y; Nishino K; Ino K; Kikkawa F
J Reprod Med; 2016 Aug; 61(7-8):373-379. PubMed ID: 30408385
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and diagnosis of early hydatidiform mole].
Jiao LZ; You SY; Wang YP; Zhu CG; Jiang JY
Zhonghua Fu Chan Ke Za Zhi; 2019 Nov; 54(11):756-762. PubMed ID: 31752459
[No Abstract] [Full Text] [Related]
13. Endometrial sampling in patients with trophoblastic disease after suction curettage.
Lertkhachonsuk R; Treratanachat S
J Reprod Med; 2008 Aug; 53(8):634-8. PubMed ID: 18773630
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of different technics of uterine evacuation as a risk factor for invasive and metastatic trophoblastic neoplasms].
de Andrade JM; Bighetti S; Kim TY; de Freitas MM
AMB Rev Assoc Med Bras; 1989; 35(5):175-8. PubMed ID: 2486413
[TBL] [Abstract][Full Text] [Related]
15. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
[TBL] [Abstract][Full Text] [Related]
16. Repeat curettage after evacuation of hydatidiform mole. An appraisal.
Lao TT; Lee FH; Yeung SS
Acta Obstet Gynecol Scand; 1987; 66(4):305-7. PubMed ID: 3122513
[TBL] [Abstract][Full Text] [Related]
17. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
18. The impact of uterine re-curettage, pre-evacuation and week-one level of hCG on the number of chemotherapy courses in treatment of post molar GTN.
Hemida RA; Toson E; Van Doorn HC
J Exp Ther Oncol; 2011; 9(3):217-20. PubMed ID: 22070053
[TBL] [Abstract][Full Text] [Related]
19. Immune cell composition in the endometrium of patients with a complete molar pregnancy: Effects on outcome.
Hoeijmakers YM; Gorris MAJ; Sweep FCGJ; Bulten J; Eysbouts YK; Massuger LFAG; Ottevanger PB; de Vries JIJM
Gynecol Oncol; 2021 Feb; 160(2):450-456. PubMed ID: 33213898
[TBL] [Abstract][Full Text] [Related]
20. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
